Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection: an Open-label Randomized Clinical Trial

NCT03854630 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT03854630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03854630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection: an Open-label Randomized Clinical Trial
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
September 6, 2017
Completion date
December 31, 2023
Enrollment
575 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, immunization; infection, viral hepatitis b